George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I've also only just spotted that your £5.7 billion pound valuation and £41 a share doesn't add up. Clearly mathematics is not your strong suit, and neither is science, or investing for that matter.
You claimed £5.7 billion valuation is equivalent to £41 a share, but with just over 200 million shares in issue for OBD this doesn't make sense. Oh dear oh dear.
Taking a number and dividing is simple, but still you managed to mess it up Kingalf.
I have no clue who money munch is, however, they clearly got under your skin. If you search, you will see that the account you are referring to is still very much active with the last post on the 22nd of Jan 2024, albeit they are invested in a different share from the looks of it. You would also note the writing style between this other account and myself is vastly different. They seem to copy and paste a lot which I do not do, while the language we use is also vastly different (You can find them by going back through the Evg pages).
Nice attempt to try to discredit me though. And it seems like you have done the same amount of research and due diligence suggesting this account, and myself, are related to one another as you do with your investments. I.e. none.
Again, more lies from you on the cash raise front, but what should we expect? Your history is clear for all to see. You spend all your time on a share BB you aren't invested in, spreading lies and misinformation in an attempt to make yourself feel better about your loss here. It must have hit you hard, otherwise why would you stay here?
Going to be even worse for you when confirmation comes through that Stalicla have applied for IND from the FDA for STP2. Then even worse when IND is approved and Stalicla have to pay Evgen $5m. Or are you suggesting that is deal with Stalicla is fake and simply a rouse by the bod, by which they would be committing fraud and liable to severe prosecution? You still haven't explained why Stalicla won't pay Evgen when they are contractually obligated to do so if the milestones are reached.
OBD hardly have a proven product, no one is buying it and I don’t think they will until they have proven during large scale, randomised trials that it is more effective than the PSA test currently available. The sale figures to date prove this. OBD will continue to drop until finding is sorted and you’ll be even further in the hole. Again, you seem to have bought the hype without doing much due diligence. OBD is going to be yet another painful lesson for you. The question is, are you going to hang around there to deramp that share as well?
While a heavily invested bod can be a good thing, it means very little when investor confidence has been shattered and cash is needed. Many companies with a heavily invested bod end up in administration and simply having a bod invested doesn't mean they have PI interests at heart. OBD bod are at the mercy of investors and what IIs are prepared to pay for the impending cash raise. From the last update, I don’t expect it to be pretty for OBD.
And do you still stick by your pie in the sky valuation of £5.7 billion, £41 a share, while the Market Cap is barely over £30 million, 16p?
Is that you money munch ?
Pro you seemed to join in September 2022 at about the same time MM disappeared.
It's important because MM was a serial ramper and was singled out by many on here for being so. Similar to yourself Pro, he/she would post endlessly to bury any negative posts and round on anyone with a contrary view. Give it a few more months and Evgen will announce another placement that will decimat existing shareholder value. Admittedly shareholders can vote against, but the alternative will be oblivion.
OBD also need to raise cash, but the bods are heavily invested and will want to minimise shareholder pain. They have a proven product in the market, while Evgen are still at the basement level hoping Stalicla will pay out when it would be more cost effective to delay any payment until next year and then pick up the rights from the receivers for peanuts.
We'll see who ends up with egg on their face, but by then you'll be using a different alias and ramping another dead beat share
Sorry my bad, OBD dropped again today, so you actually need a 25700% rise.
Says the guy that valued OBD at over 150 times its prevailing share price, at £5.7 Billion, yes 5.7 billion pounds, making it a FTSE 100 behemoth. The delusion is unreal. I can almost guarantee OBD will NEVER be valued at £41 per share, unless a massive consolidation occurs. Only 20000% increased need Kingalf for your target and you have the audacity to suggest we’re in cuckoo land. Hahahahaha
The evidence suggests you're going to have egg on your face very soon. Looking forward to it.
If you think Stalicla will pay Evgen anything your all living in CCL.
Pro, your posts are reminiscent of Money Munch who used to continually ramp this up, and dissenting views were slapped down but all the while the share price continued to drop.
Obviously wouldn't expect them to be still using the same alias as they were completely discredited. Any connection ?
As for OBD, they have a product adopted by Bupa and are a million miles further down the road than Evgen.